AHC Ballana Heart Study (AHC-BHS)

Magdi Yacoub Heart Foundation

Status: Enrolling

Conditions: Genetic Predisposition to Disease

Treatments: Other: Risk assessment

Study type: Observational

Funder types: Other

Identifiers

NCT05661318

AHC-BHS

Details and patient eligibility

About

This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.

Full description

Background Population-based longitudinal studies are a cornerstone in understanding current disease landscapes affecting communities and collecting reliable data to guide prevention and treatment strategies. In Egypt there is pressing need of collecting reliable data on cardiovascular disease (CVD) in defined populations.

Objectives Defining the cardiovascular phenotype, genotype as well as OMICS and risk factors for CVD in a defined population in Egypt with follow up for up to 30 years

Methods As a first step, a random representative sample of 1,200 households from the Ballana population will be created. Following inclusion, patients will be screened for their cardiovascular profile and followed up for changes in their profile and cardiovascular events continuously every year in high risk patients and every 3 years for the rest of the participants for a period of 30 years.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Residents of Ballana from the 1,200 randomly selected households
• Participants must have a valid National ID card
• Written informed consent

Exclusion criteria

• Residents who are younger than 18 years

Trial design

5,000 participants in 1 patient group

BHS

Description:

Residents of Ballana from the 1,200 randomly selected households

Treatment:

Other: Risk assessment